AJP - Regulatory, Integrative and Comparative Physiology, Vol 268, Issue 1 135-R141, Copyright © 1995 by American Physiological Society

ARTICLES

Identification of gastrin as a growth peptide in human pancreatic cancer

J. P. Smith, A. P. Fantaskey, G. Liu and I. S. Zagon
Department of Medicine, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.

The present study reports the first evidence that the gastrointestinal peptide gastrin stimulates the growth of several human pancreatic cancer cells in culture and in tumors transplanted to nude mice. Gastrin promoted growth of all cell lines tested at a dose comparable to the binding affinity, providing evidence for a physiologically relevant receptor. The stimulatory effects of gastrin were blocked by the CCK-B/gastrin receptor antagonist L-365,260 and not by the CCK-A receptor antagonist L-364,718. Growth of PANC-1 cells in culture were inhibited by L-365,260, suggesting that gastrin is tonically produced by PANC-1 cells for regulation of growth. Athymic nude mice bearing PANC-1 xenografts were treated for 24 days subcutaneously with either 1% bovine serum albumin (diluent), pentagastrin (1 mg/kg), or L-365,260 (1 mg/kg) twice daily. Tumors from the pentagastrin-treated mice were found to weigh more and have greater protein and DNA content than controls, whereas these values were all decreased in tumors of L-365,260-treated mice. Receptor binding capacity changed in tumors of animals treated with the peptide or antagonist, suggesting a regulatory process. Gastrin immunoreactivity was detected in a transplanted PANC-1 human tumor. These results identify gastrin as a potent trophic peptide that actively stimulates growth of human pancreatic cancer and does so through a CCK-B/gastrin-like receptor.

This article has been cited by other articles:

				F. G. El Kamar, M. L. Grossbard, and P. S. Kozuch Metastatic Pancreatic Cancer: Emerging Strategies in Chemotherapy and Palliative Care Oncologist, February 1, 2003; 8(1): 18 - 34. [Abstract] [Full Text] [PDF]

				B. T. Brett, S. C. Smith, C. V. Bouvier, D. Michaeli, D. Hochhauser, B. R. Davidson, T. R. Kurzawinski, A. F. Watkinson, N. Van Someren, R. E. Pounder, et al. Phase II Study of Anti-Gastrin-17 Antibodies, Raised to G17DT, in Advanced Pancreatic Cancer J. Clin. Oncol., October 15, 2002; 20(20): 4225 - 4231. [Abstract] [Full Text] [PDF]

				L. G. Tillotson RIN ZF, a Novel Zinc Finger Gene, Encodes Proteins That Bind to the CACC Element of the Gastrin Promoter J. Biol. Chem., March 19, 1999; 274(12): 8123 - 8128. [Abstract] [Full Text] [PDF]

				J. F. REHFELD The New Biology of Gastrointestinal Hormones Physiol Rev, October 1, 1998; 78(4): 1087 - 1108. [Abstract] [Full Text] [PDF]

				S. S. Glaser, R. E. D. Rodgers, J. L. Phinizy, W. E. Robertson, J. Lasater, A. Caligiuri, Z. Tretjak, G. D. Lesage, and G. Alpini Gastrin inhibits secretin-induced ductal secretion by interaction with specific receptors on rat cholangiocytes Am J Physiol Gastrointest Liver Physiol, November 1, 1997; 273(5): G1061 - G1070. [Abstract] [Full Text] [PDF]